Patent Assignment
Reel/Frame 023525/0915
Change of Name
Recorded: 2009-11-18
Pages: 33
Assignor
4523482 CANADA INC.
Executed: 2009-08-25
Assignee
CONJUCHEM BIOTECHNOLOGIES INC.
225 PRESIDENT-KENNEDY AVENUE, SUITE 3950, MONTREAL, QUEBEC, H2X 3Y8, CANADA
Covered Property
(1)
Long-Lasting Antiviral Fusion Inhibitor Peptide Conjugates Comprising Albumin and Human Immunodeficiency Virus (Hiv) Peptides.
Patent:
7,582,301 →
Application:
09/623,533 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 5, 2000
From: BRIDON, DOMINIQUE P.; DUFRESNE, ROBERT S.; BOUDJELLAB, NISSAB; ROBITAILLE, MARTIN
To: CONJUCHEM, INC.
Reel/Frame 011186/0640 →
Assignment of Assignor's Interest
Aug 1, 2006
From: CONJUCHEM INC.
To: CONJUCHEM BIOTECHNOLOGIES INC.
Reel/Frame 018039/0669 →
Assignment of Assignor's Interest
Nov 18, 2009
From: CONJUCHEM BIOTECHNOLOGIES INC.
To: 4523482 CANADA INC.
Reel/Frame 023525/0853 →
Assignment of Assignor's Interest
Oct 26, 2010
From: CONJUCHEM BIOTECHNOLOGIES INC.
To: ADVANCED DIAGNOSTICS AND DISCOVERY
Reel/Frame 025198/0735 →
Assignment of Assignor's Interest
Apr 20, 2011
From: ADVANCED DIAGNOSTICS AND DISCOVERY
To: CONJUCHEM, LLC
Reel/Frame 026157/0022 →